DrugPatentWatch Database Preview

Details for Patent: 9,233,118

Which drugs does patent 9,233,118 protect, and when does it expire?

Patent 9,233,118 protects SOOLANTRA and is included in one NDA.

This patent has twenty-nine patent family members in thirteen countries.

Summary for Patent: 9,233,118

Title:	Treatment of papulopustular rosacea with ivermectin
Abstract:	Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
Inventor(s):	Jacovella; Jean (Antibes, FR), Chappuis; Jean-Paul (Valbonne, FR), Kaoukhov; Alexandre (Newport Beach, CA), Graeber; Michael (Lawrenceville, NJ), Poncet; Michel (Mougins, FR), Briantais; Philippe (Antibes, FR), Salin; Laurence (La Roquette sur Siagne, FR)
Assignee:	Galderma S.A. (Cham, CH)
Application Number:	14/209,958
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,233,118

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Galderma Labs Lp	SOOLANTRA	ivermectin	CREAM;TOPICAL	206255-001	Dec 19, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 9,233,118

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,782,425	Treatment of papulopustular rosacea with ivermectin	➤ Sign Up
9,089,587	Treatment of papulopustular rosacea with ivermectin	➤ Sign Up
9,233,117	Treatment of inflammatory lesions of rosacea with ivermectin	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 9,233,118

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014287408	➤ Sign Up
Australia	2014287422	➤ Sign Up
Canada	2916668	➤ Sign Up
Canada	2916704	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 9,233,118

For more information try a trial or see the plans and pricing